 |
 |

Treatment of Gastric UlcerWhat Is Old and What Is New
James H. Lewis, MD
Arch Intern Med. 1983;143(2):264-274.
Abstract
The rational treatment of gastric ulcer (GU) requires both an understanding of the various causative factors responsible for what is best considered a spectrum of disorders, as well as a familiarity with the newer antisecretory and cytoprotective therapies that are available. Gastric ulcers that fulfill the criteria to be peptic ulcers (ie, occur in the antrum in the presence of excess luminal acid, with or without a coexisting duodenal ulcer) are best treated with a histamine H2-receptor antagonist. For GUs that develop in the setting of normal or reduced acid output, or those that occur as a result of direct (ie, drug-induced or bile acid-related) mucosal injury, use of a cytoprotective agent (eg, sucralfate) is the treatment of choice. Any GU that falls to heal within 12 to 15 weeks should be carefully examined to exclude the presence of a malignant neoplasm and should be considered for surgical resection.
(Arch Intern Med 1983;143:264-274)
Author Affiliations
From the Department of Medicine, Division of Gastroenterology, George Washington School of Medicine and Health Sciences, Washington, DC.
Footnotes
Accepted for publication Sept 20, 1982.
Reprint requests to the Department of Medicine, Division of Gastroenterology, George Washington School of Medicine and Health Sciences, 2150 Pennsylvania Ave NW, Washington, DC 20037 (Dr Lewis).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Benign Gastric Ulcer and Cimetidine: Questions About Study Design
SACHERE
ANN INTERN MED 1985;103:636-637.
ABSTRACT
Healing of Benign Gastric Ulcer: Comparison of Cimetidine and Placebo in the United States
GRAHAM et al.
ANN INTERN MED 1985;102:573-576.
ABSTRACT
|